CD9 and COVID-19: The total number of proteins identified in CD9+-EVs showed a slight decrease in severe COVID-19 patients at the convalescent stage (Supplementary Figure 9A) and remained unchanged in mild/asymptomatic COVID-19 and control group (Supplementary Figures 9B, C).